Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line

Cellular Immunology

Volumn 256, Issue 1-2, 2009, Pages 19-26

  Li, Ying Ying ^a,b   Hsieh, Ling Ling ^b   Tang, Rei Ping ^b   Liao, Shuen Keui ^c   Yeh, Kun Yun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Colon cancer; IL 6; Macrophages; Mucin

Indexed keywords

CD68 ANTIGEN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MONOCLONAL ANTIBODY; MUCIN 1; MUCIN 2; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASE SEQUENCE; COLONIC NEOPLASMS; DNA PRIMERS; DOWN-REGULATION; FEMALE; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MACROPHAGES; MALE; MIDDLE AGED; MUCIN-1; MUCIN-2; PHOSPHORYLATION; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR; TYROSINE; UP-REGULATION;

EID: 62249090997     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.01.001     Document Type: Article

References (42)

1. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16 (1998) 249-284
2. Harroch S., Revel M., and Chebath J. Interleukin-6 signaling via four transcription factors binding palindromic enhancers of different genes. J. Biol. Chem. 269 (1994) 26191-26195
3. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
4. Syed V., Ulinski G., Mok S.C., and Ho S.M. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J. Natl. Cancer Inst. 94 (2002) 617-629
5. Sriuranpong V., Park J.I., Amornphimoltham P., Patel V., Nelkin B.D., and Gutkind J.S. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 63 (2003) 2948-2956
6. Giri D., Ozen M., and Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am. J. Pathol. 159 (2001) 2159-2165
7. Schneider M.R., Hoeflich A., Fischer J.R., Wolf E., Sordat B., and Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 151 (2000) 31-38
8. Dansky-Ullmann C., Salgaller M., Adams S., Schlom J., and Greiner J.W. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta. Cytokine 7 (1995) 118-129
9. Herbeuval J.P., Lelievre E., Lambert C., Dy M., and Genin C. Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J. Immunol. 172 (2004) 4630-4636
10. Inaba T., Sano H., Kawahito Y., Hla T., Akita K., Toda M., Yamashina I., Inoue M., and Nakada H. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 2736-2741
11. Byrd J.C., and Bresalier R.S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23 (2004) 77-99
12. Miyake M., Taki T., Hitomi S., and Hakomori S. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N. Engl. J. Med. 327 (1992) 14-18
13. Symonds D.A., and Vickery A.L. Mucinous carcinoma of the colon and rectum. Cancer 37 (1976) 1891-1900
14. Green J.B., Timmcke A.E., Mitchell W.T., Hicks T.C., Gathright Jr. J.B., and Ray J.E. Mucinous carcinoma-just another colon cancer?. Dis. Colon Rectum. 36 (1993) 49-54
15. Consorti F., Lorenzotti A., Midiri G., and Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J. Surg. Oncol. 73 (2000) 70-74
16. Nozoe T., Anai H., Nasu S., and Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J. Surg. Oncol. 75 (2000) 103-107
17. Nakamori S., Ota D.M., Cleary K.R., Shirotani K., and Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106 (1994) 353-361
18. Baldus S.E., Monig S.P., Hanisch F.G., Zirbes T.K., Flucke U., Oelert S., Zilkens G., Madejczik B., Thiele J., Schneider P.M., Holscher A.H., and Dienes H.P. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology 40 (2002) 440-449
19. Enss M.L., Cornberg M., Wagner S., Gebert A., Henrichs M., Eisenblatter R., Beil W., Kownatzki R., and Hedrich H.J. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm. Res. 49 (2000) 162-169
20. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
21. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., Oshima M., and Taketo M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med. 7 (2001) 1048-1051
22. Yokoigawa N., Takeuchi N., Toda M., Inoue M., Kaibori M., Yanagida H., Tanaka H., Ogura T., Takada H., Okumura T., Kwon A.H., Kamiyama Y., and Nakada H. Enhanced production of interleukin 6 in peripheral blood monocytes stimulated with mucins secreted into the bloodstream. Clin. Cancer Res. 11 (2005) 6127-6132
23. D. Piancatelli, P. Romano, P. Sebastiani, D. Adorno, C.U. Casciani, Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression, J. Immunother. (1997) 22 (1999) 25-32.
24. Lieubeau B., Heymann M.F., Henry F., Barbieux I., Meflah K., and Gregoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int. J. Cancer 81 (1999) 629-636
25. Khorana A.A., Ryan C.K., Cox C., Eberly S., and Sahasrabudhe D.M. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 97 (2003) 960-968
26. Banner B.F., Savas L., Baker S., and Woda B.A. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 64 (1993) 213-220
27. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278 (2003) 17036-17043
28. Gaemers I.C., Vos H.L., Volders H.H., van der Valk S.W., and Hilkens J. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem. 276 (2001) 6191-6199
29. Hudson J.D., Shoaibi M.A., Maestro R., Carnero A., Hannon G.J., and Beach D.H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190 (1999) 1375-1382
30. Talos F., Mena P., Fingerle-Rowson G., Moll U., and Petrenko O. MIF loss impairs Myc-induced lymphomagenesis. Cell Death Differ. 12 (2005) 1319-1328
31. Ookawa K., Kudo T., Aizawa S., Saito H., and Tsuchida S. Transcriptional activation of the MUC2 gene by p53. J. Biol. Chem. 277 (2002) 48270-48275
32. McBride W.H. Phenotype and functions of intratumoral macrophages. Biochim. Biophys. Acta 865 (1986) 27-41
33. Hermanowicz A., Gibson P.R., and Jewell D.P. Tumour related inhibition of macrophage chemotaxis in patients with colon cancer. Gut 28 (1987) 416-422
34. Takahashi Y., Bucana C.D., Liu W., Yoneda J., Kitadai Y., Cleary K.R., and Ellis L.M. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst. 88 (1996) 1146-1151
35. Funada Y., Noguchi T., Kikuchi R., Takeno S., Uchida Y., and Gabbert H.E. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol. Rep. 10 (2003) 309-313
36. Sickert D., Aust D.E., Langer S., Haupt I., Baretton G.B., and Dieter P. Characterization of macrophage subpopulations in colon cancer using tissue microarrays. Histopathology 46 (2005) 515-521
37. Matsushita Y., Cleary K.R., Ota D.M., Hoff S.D., and Irimura T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest. 63 (1990) 780-791
38. Irimura T., Matsushita Y., Hoff S.D., Yamori T., Nakamori S., Frazier M.L., Giacco G.G., Cleary K.R., and Ota D.M. Ectopic expression of mucins in colorectal cancer metastasis. Semin. Cancer Biol. 2 (1991) 129-139
39. You J.F., Hsieh L.L., Changchien C.R., Chen J.S., Chen J.R., Chiang J.M., Yeh C.Y., Hsieh P.S., Fan C.W., Liu C.T., and Tang R. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin. Cancer Res. 12 (2006) 4244-4250
40. Erroi A., Sironi M., Chiaffarino F., Chen Z.G., Mengozzi M., and Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer 44 (1989) 795-801
41. Jourdan M., Zhang X.G., Portier M., Boiron J.M., Bataille R., and Klein B. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. J. Immunol. 147 (1991) 4402-4407
42. Cromwell O., Hamid Q., Corrigan C.J., Barkans J., Meng Q., Collins P.D., and Kay A.B. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 77 (1992) 330-337